By www.reliablemarketinsights.com
Global Peripheral Arterial Disease (PAD) Drugs Market Size, Status And Forecast 2024-2031 Story
96
$ 3900
Peripheral Arterial Disease (PAD) Drugs Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
AstraZeneca (UK)
Bayer HealthCare Pharmaceuticals (Germany)
Bristol-Myers Squibb Company (US)
Merck & Co (US)
Proteon Therapeutics (US)
Sanofi (France)
Symic Bio (US)
TheraVasc (US)